ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Stoke Therapeutics Inc

Stoke Therapeutics Inc (STOK)

12.11
0.20
( 1.68% )
Updated: 12:10:16

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.91M3.27M5.15M-2.48M3.31M2.8M4.22M4.83M
Operating Income -27.15M-27.18M-24.69M-33.26M-27.23M-29.59M-28.37M-29.34M
Pre Tax Income -26.11M-25.66M-22.55M-30.65M-24.54M-26.96M-26.37M-25.7M
Net Income -26.11M-25.66M-22.55M-30.65M-24.54M-26.96M-26.37M-25.7M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -27.11M-27.13M-24.65M-33.22M-27.19M-29.55M-28.8M-29.39M
EBITDA -26.76M-26.57M-24.09M-32.65M-26.6M-28.96M-27.81M-28.79M
Year End December 30 2023 2017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0000012.41M8.78M
Operating Income -5.55M-12.78M-35.68M-53.04M-86.07M-104.36M-114.77M
Pre Tax Income -5.56M-12.52M-32.33M-52.24M-85.81M-101.07M-104.7M
Net Income -5.56M-12.52M-32.33M-52.24M-85.81M-101.07M-104.7M
Preferred Dividends 0000000
Basic Earnings Per Share (EPS) -0.834-0.054-0.125-0.199-0.327-0.381-0.387
EBIT -5.56M-12.79M-35.68M-52.99M-85.93M-104.19M-114.61M
EBITDA -5.44M-12.57M-35.23M-52.16M-85.09M-102.81M-112.3M

Your Recent History

Delayed Upgrade Clock